Neoadjuvant Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Neoadjuvant Radiotherapy for Breast Cancer
Conditions: Neoadjuvant Radiotherapy; Breast Cancer Interventions: Radiation: Neoadjuvant radiotherapy; Radiation: adjuvant radiotherapy Sponsors: Changhai Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Trial
Conditions: Gastric Cancer; Esophagogastric Junction Cancer Interventions: Drug: Cadonilimab; Drug: Oxaliplatin; Drug: Capecitabine Sponsors: Nanfang Hospital, Southern Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy
Conditions: Breast Neoplasms Interventions: Drug: Carrellizumab + Capecitabine; Drug: Placebo + Capecitabine Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Radiotherapy; Complications; IMMUNOTHERAPY Interventions: Radiation: de-escalated radiotherapy; Radiation: conventional radiotherapy Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy
Conditions: Prehabilitation; Breast Cancer; Postmenopause; Resistance Training Interventions: Other: Prehabilitation with resistance-exercise training Sponsors: Universidad de La Frontera Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials

Neoadjuvant SBRT in Localized Advanced HNSCC
Conditions: Head and Neck Squamous Carcinoma Interventions: Radiation: SBRT+immunochemotherpy; Drug: Immunochemotherapy; Drug: cetuximab+immunochemotharpy Sponsors: Jiang Feng Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials

Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Cancer Interventions: Drug: Combination of pembrolizumab and platinum containing dual drugs Sponsors: Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
Conditions: Ovarian Cancer Interventions: Behavioral: Assess the response to platinum-based chemotherapy in correlation to BRCA status in neoadjuvant and recurrent ovarian cancer Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

A Single Arm, Single Center, Phase II Clinical Study of Pembrolizumab Combined With Preoperative Chemotherapy (Albumin Paclitaxel+Carboplatin) Neoadjuvant Therapy for Resectable Locally Advanced (Stage II/III) Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Cancer Interventions: Drug: Combination of pembrolizumab and platinum containing dual drugs Sponsors: Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma
Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: paclitaxel; Drug: carboplatin; Drug: tislelizumab; Radiation: radiotherapy Sponsors: Qiu Guoqin Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
Conditions: Locally Advanced Rectal Cancer Interventions: Combination Product: Long-course chemoradiation and PD-1 inhibitor, with PCSK9 inhibitor; Combination Product: Long-course chemoradiation and PD-1 inhibitor, without PCSK9 inhibitor Sponsors: Beijing Friendship Hospital; Peking Union Medical College Hospital; Peking University Cancer Hospital& Institute; Changhai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
Conditions: Non Small Cell Lung Cancer; EGFR Gene Mutation Interventions: Drug: almonertinib; Drug: Carboplatin; Drug: Nab paclitaxel Sponsors: Guangdong Provincial People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
Conditions: Rectal Cancer Interventions: Drug: irinotecan liposomes+capecitabine Sponsors: Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells
Conditions: Malignant Bone Tumor Interventions: Drug: narlumosbartmab plus doxorubicin 、cisplatin、methotrexate、ifosfamide; Drug: doxorubicin、cisplatin、methotrexate、ifosfamide Sponsors: Peking University People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy
Conditions: Breast Cancer Interventions: Procedure: Neoadjuvant chemotherapy; Procedure: Adjuvant chemotherapy Sponsors: Seoul National University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials